Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 2;8(11):937-40.
doi: 10.1038/nmeth.1714.

MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics

Lily Ting  1 , Ramin Rad, Steven P Gygi, Wilhelm Haas
Affiliations

MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics

Lily Ting et al. Nat Methods. .

Abstract

Quantitative mass spectrometry-based proteomics is highly versatile but not easily multiplexed. Isobaric labeling strategies allow mass spectrometry-based multiplexed proteome quantification; however, ratio distortion owing to protein quantification interference is a common effect. We present a two-proteome model (mixture of human and yeast proteins) in a sixplex isobaric labeling system to fully document the interference effect, and we report that applying triple-stage mass spectrometry (MS3) almost completely eliminates interference.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Isobaric labeling, interference and interference modeling. (a) Quantitative mass spectrometry-based proteomics experiments with stable isotope containing isobaric tags (TMT or iTRAQ) produce differentially labeled peptide ions that are indistinguishable in full-MS spectra. Quantification is based on low m/z reporter fragment ion intensities after a target ion is isolated and fragmented in an MS2 experiment. (b) Both accuracy and precision of peptide quantification are affected when contaminating peptide ions (red) are co-isolated with the target peptide ion (blue), a phenomenon that we term the interference effect. (c) Accurate measurement of the interference effect by a multi-proteome model using TMT six-plex labeled human cell line and S. cerevisiae Lys-C digests. The first three channels model interference, where yeast peptides were combined to create three different ratios (10:1, 4:1, 2.5:1) amongst unchanging interfering human peptides (1:1:1). In the last three channels, yeast peptides were combined in the same ratios (mirrored relative to the first three channels) without any human peptide interference. (d) An ideal yeast peptide MS2 spectrum without human peptide interference in the first three channels would have identical and mirrored TMT reporter ion intensities in the last three channels. (e) A typical yeast peptide has some degree of interference in the first three reporter ion channels (red shaded box), which results in ratio distortion towards 1:1:1.
Figure 2
Figure 2
Evaluation and attempted removal of the interference effect. (a) An example of strong distortion of reporter ion intensities for a yeast peptide ion by interference of human peptide ions (left) and the effect of interference by yeast peptides on the reporter ion intensities of a human peptide (right; signals in channels 129, 130, and 131). (b) Ratiodistributions (log2) of yeast (Y) peptides in channels with human (H) peptide interference (blue line), without human peptide interference (red line), and human peptides only (gray dashed line) for the predicted ratios 2.5:1 (left), 4:1 (middle), and 10:1 (right). LC-MS2 data were collected after separating the yeast and human whole cell lysate digest into 20 fractions using SCX. (c) Averaged normalized relative intensities for each TMT reporter ion channel for yeast peptides (left), and human peptides (right) from the dataset described in (b). Error bars represent one standard deviation for 20,272 and 81,180 yeast and human peptides, respectively. (d) There was minimal improvement of yeast peptide ratios in channels with human peptide interference (126, 127, and 128) with post-acquisition data filtering of isolation specificity (IS; left), fractionation (middle) and precursor isolation width (right). Expected ratios were divided by measured ratios, where perfect ratios would have a value of 1 for all three axes (red triangle). The greater the distance of each tested condition from the red perfect ratio triangle, the greater the influence of human peptide interference on yeast peptide ratio distortion. Increasing dynamic range results in greater ratio distortion.
Figure 3
Figure 3
An MS3-based method eliminates the interference effect. (a) Our MS3 method separates quantification from peptide identification. Fast LTQ-CID-MS2 experiments are used for peptide sequence assignments, followed by the selection of the most intense fragment ion from MS2 (green shading) for HCD-MS3, within a 110–160% m/z range relative to the precursor ion m/z value (gray box), where TMT reporter ion intensities are measured in the Orbitrap. (b) Normalized intensities for each TMT reporter ion channel for yeast peptides (left), and human peptides (right). Almost no interference effect was measured, except for forward false positives (1.5%). Error bars represent one standard deviation for 8,919 and 65,595 yeast and human peptides, respectively (c) Yeast peptide ratios from dataset combining 20 SCX fractions. Ratios were substantially compressed in channels containing interference when quantification was based on MS2 spectra. Using MS3 for quantification, measured yeast peptide ratios from channels also containing human peptides (126, 127, 128) were very close to ratios measured for channels that contained only yeast peptide ions (129, 130, 131). Error bars represent one standard deviation for 29,813, 22,640 and 7,173 peptides for Average, MS2 and MS3 analyses, respectively. (d) Ratio distribution (log2 scale) of yeast (Y) peptides in channels with human (H) peptide interference (blue line), without human peptide interference (red line), and for human peptides (gray dashed line) for 2.5:1 (left), 4:1 (middle), and 10:1 (right) combinations.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aebersold R, Mann M. Nature. 2003;422:198–207. - PubMed
    1. Ross PL, et al. Mol Cell Prot. 2004;3:1154–1169. - PubMed
    1. Dayon L, et al. Anal Chem. 2008;80:2921–2931. - PubMed
    1. Thompson A, et al. Anal Chem. 2003;75:1895–1904. - PubMed
    1. Choe L, et al. Proteomics. 2007;7:3651–3660. - PMC - PubMed

Publication types